High-avidity CD8+ T cells -: Optimal soldiers in the war against viruses and tumors

被引:62
作者
Alexander-Miller, MA [1 ]
机构
[1] Wake Forest Univ, Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27157 USA
关键词
avidity; viral clearance; CD8(+); T cells; tumors; regulation;
D O I
10.1385/IR:31:1:13
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The primary goal of vaccination is the establishment of protective immunity. Thus there has been significant effort put toward the identification of attributes of the immune response that are associated with optimal protection. Although the number of virus-specific cells elicited is unquestionably important, recent studies have identified an additional parameter, functional avidity, as critical in determining the efficiency of viral clearance. T-cell avidity is a measure of the sensitivity of a cell to peptide antigen. High-avidity cells are those that can recognize antigen-presenting cells (APC) bearing very low levels of peptide antigen, whereas low-avidity cells require much higher numbers of peptide major histocompatibility complex (MHC) complexes in order to become activated or exert effector function. We are only now beginning to gain insights into the molecular control of avidity and the signals required for the optimal activation, expansion, and retention of high-avidity cells in vivo. This review summarizes the current knowledge regarding CD8(+) T-cell avidity and explores some of the important issues that are, as of yet, unresolved.
引用
收藏
页码:13 / 24
页数:12
相关论文
共 50 条
[1]   Supraoptimal peptide major histocompatibility complex causes a decrease in Bcl-2 levels and allows tumor necrosis factor α receptor II-mediated apoptosis of cytotoxic T lymphocytes [J].
Alexander-Miller, MA ;
Derby, MA ;
Sarin, A ;
Henkart, PA ;
Berzofsky, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (08) :1391-1399
[2]   Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL [J].
AlexanderMiller, MA ;
Leggatt, GR ;
Sarin, A ;
Berzofsky, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :485-492
[3]   Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy [J].
AlexanderMiller, MA ;
Leggatt, GR ;
Berzofsky, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (09) :4102-4107
[4]  
ALRAMADI BK, 1995, J IMMUNOL, V155, P662
[5]   HIV-specific CD8+ T cells produce antiviral cytokines but are impaired in cytolytic function [J].
Appay, V ;
Nixon, DF ;
Donahoe, SM ;
Gillespie, GMA ;
Dong, T ;
King, A ;
Ogg, GS ;
Spiegel, HML ;
Conlon, C ;
Spina, CA ;
Havlir, DV ;
Richman, DD ;
Waters, A ;
Easterbrook, P ;
McMichael, AJ ;
Rowland-Jones, SL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (01) :63-75
[6]   Antigen density presented by dendritic cells in vivo differentially affects the number and avidity of primary, memory, and recall CD8+ T cells [J].
Bullock, TNJ ;
Mullins, DW ;
Engelhard, VH .
JOURNAL OF IMMUNOLOGY, 2003, 170 (04) :1822-1829
[7]   Manipulation of avidity to improve effectiveness of adoptively transferred CD8+ T cells for melanoma immunotherapy in human MHC class I-transgenic mice [J].
Bullock, TNJ ;
Mullins, DW ;
Colella, TA ;
Engelhard, VH .
JOURNAL OF IMMUNOLOGY, 2001, 167 (10) :5824-5831
[8]   T cell affinity maturation by selective expansion during infection [J].
Busch, DH ;
Pamer, EG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (04) :701-709
[9]   Optimal colocalization of TCR and CD8 as a novel mechanism for the control of functional avidity [J].
Cawthon, AG ;
Alexander-Miller, MA .
JOURNAL OF IMMUNOLOGY, 2002, 169 (07) :3492-3498
[10]   Peptide requirement for CTL activation reflects the sensitivity to CD3 engagement:: Correlation with CD8αβ versus CD8αα expression [J].
Cawthon, AG ;
Lu, HP ;
Alexander-Miller, MA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (05) :2577-2584